HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Prednisone (Sone)

A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

Also Known As:

Sone; Cortan; Deltasone; Liquid Pred; Winpred; Apo-Prednisone; Apotex Brand of Prednisone; Aventis Brand of Prednisone; Cortancyl; Cutason; Dacortin; Decortin Brand of Prednisone; Decortisyl; Diba Brand of Prednisone; Encorton; Encortone; Enkortolon; Fawns & McAllan Brand of Prednisone; Ferring Brand of Prednisone; GALENpharma Brand of Prednisone; Halsey Drug Brand of Prednisone; Hexal Brand of Prednisone; Hoechst Brand of Prednisone; ICN Brand of Prednisone; Kortancyl; Lichtenstein Brand of Prednisone; Merck Brand of Prednisone; Merz Brand of Prednisone; Meticorten; Orasone; Panafcort; Panasol; Pharmacia Brand of Prednisone; Predni Tablinen; Prednidib; Predniment; Prednison Galen; Prednison Hexal; Prednison acsis; Pronisone; Rectodelt; Schering-Plough Brand of Prednisone; Seatrace Brand of Prednisone; Solvay Brand of Prednisone; Sterapred; Trommsdorff Brand of Prednisone; Ultracorten; acis Brand of Prednisone; mibe Brand of Prednisone; Dehydrocortisone; delta-Cortisone; Pregna-1,4-diene-3,11,20-trione, 17,21-dihydroxy-

Networked: 8946 relevant articles (1136 outcomes, 1285 trials/studies)

Relationship Network

Drug Context: Research Results

Polycyclic Compounds: 56
- Steroids: 18537
  - Pregnanes: 3
    - Pregnadienes
      - Pregnadienediols
        Prednisone: 8946
        CHOP-B protocol: 67
        CMFVP protocol: 36
        PROMACE-CytaBOM protocol: 33
        CHOP protocol: 29
        LSA2-L2 protocol: 29
        PVDA protocol: 26
        COPP protocol: 22
        M-2 protocol: 19
        OPEN protocol: 13
        ESHAP regimen: 10
        CHVP protocol: 8
        AP protocol 2: 7
        COP-BLAM protocol: 7
        OPPA protocol: 7
        BFM 78 protocol: 5
        VACOP-B protocol: 5
        CEOP-B protocol: 4
        CMFPT protocol: 4
        LMB89 protocol: 4
        MACOP-B protocol: 4
        meprednisone: 4
        THP-COPBLM regimen: 4
        AMSA-OAP protocol: 3
        BEACOPP protocol: 3
        COMP protocol: 3
        LNH 87 protocol: 3
        MOPP protocol: 3
        New York protocol: 3
        ABEP protocol 2: 2
        CAMP combination: 2
        CCG-141 protocol: 2
        FMP regimen: 2
        VMCP protocol: 2
        ACOPA II protocol: 1
        ACP protocol: 1
        AIEOP acute lymphoblastic leukemia protocol: 1
        AVBP protocol: 1
        BVCPP protocol: 1
        CEOP protocol 1: 1
        COBDP regimen: 1
        COP protocol 2: 1
        EPOCH protocol: 1
        LOPP protocol 2: 1
        MiNa protocol: 1
        Nisone: 1
        NOP-bolus regimen: 1
        OAP protocol: 1
        OPP-EBV-CAD regimen: 1
        oxycyclosol: 1
        ProMACE-MOPP protocol: 1
        protocol 8001: 1
        RAP protocol: 1
        Stanford V protocol: 1
        U 72099E: 1
        20-dihydroprednisone
        21-fluoroprednisone
        6-methylprednisone
        ABDIC protocol
        ABP protocol 1
        ABVDP protocol
        ACMFVP protocol
        ACOP protocol 2
        ADOAP protocol
        AIEOP 8703 protocol
        AIEOP protocol 8202
        ALL-1 protocol
        AOAP protocol
        AOPE protocol
        APC protocol
        APO combination
        B-DOPA protocol
        BAPP protocol
        BCP protocol
        BCPE protocol
        BCVP protocol
        BECALM protocol
        BFM-86 protocol
        BMP protocol
        BVMP regimen
        BVP protocol
        CAFVP protocol
        CAPE protocol
        CAVP protocol
        CBVPM protocol
        CCNU-VP protocol
        CCVPP protocol
        CDOP protocol
        CDPTH regimen
        CEMP protocol
        CEOP-MB protocol
        CEPP protocol
        CFP protocol
        CHEP protocol
        CHIVPP protocol
        CHV-mP-VB protocol
        CHVmP-VB protocol
        CHVP regimen
        CIOP-Bleo protocol
        CIP protocol
        CisEBP protocol

Experts

1.	Palumbo, Antonio: 37 articles (12/2015 - 10/2005)
2.	Pfreundschuh, Michael: 25 articles (10/2014 - 01/2002)
3.	Boccadoro, Mario: 24 articles (12/2015 - 10/2005)
4.	Gascoyne, Randy D: 20 articles (09/2015 - 08/2005)
5.	Coiffier, Bertrand: 20 articles (04/2015 - 01/2002)
6.	Petrucci, Maria Teresa: 17 articles (12/2015 - 01/2002)
7.	Bringhen, Sara: 17 articles (10/2014 - 03/2006)
8.	Engert, Andreas: 17 articles (01/2014 - 01/2002)
9.	Small, Eric J: 16 articles (10/2015 - 10/2004)
10.	Ryan, Charles J: 16 articles (10/2015 - 03/2007)

Related Diseases

1.	Nephrotic Syndrome (Syndrome, Nephrotic) 02/20/1988 - "Complete initial remission of steroid responsive nephrotic syndrome can be obtained with half the standard prednisone dose, but the short course is followed by a higher rate of relapses, that require repeated prednisone administrations. " 03/01/1975 - " Thirty-four patients had been treated with prednisone; initial complete remission of the nephrotic syndrome occurred in only 4 patients and partial remission in 10. " 05/15/1971 - "Five of the elderly patients with minimal change lesion were treated with prednisone-in four a complete remission from the nephrotic syndrome followed, while the fifth patient's course is unknown.These" 04/01/2009 - "Among the adult Chinese patients with MSNS-HBV who completed this study, there were no significant differences in remission rates of idiopathic nephrotic syndrome between the standard prednisone regimen and the combination of MMF and a reduced prednisone dose. " 08/02/1980 - "Seven patients with slight but definite proliferative changes in the glomeruli achieved complete remission of the nephrotic syndrome when treated with prednisone. "
2.	Lymphoma (Lymphomas) 02/10/2015 - "Right atrial lymphoma: rapid relief of TV obstruction by prednisone." 11/01/1999 - "A favorable response of the subcutaneous induration to prednisone treatment does not exclude the diagnosis of lymphoma; therefore, it does not supersede the need of a pathological evaluation. " 09/01/1992 - "Prednisone with or without COPBLAM/IMVP-16 treatment in AILD-type lymphoma leads to complete remissions in about half of the patients and in long-term, disease-free survival for one third." 01/01/1990 - "We conclude that in this patient AILD and prednisone administration constituted favoring factors for the development of an extranodal lymphoma." 02/01/1984 - "Hypothalamic-pituitary-adrenal function in patients receiving intermittent high dose prednisone therapy for lymphoma."
3.	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell) 07/01/1981 - "Four patients with diffuse histiocytic lymphoma (group 1) received prednisone for 5 days every 3 weeks for five courses, and five patients with Hodgkin's disease (group 2) received prednisone for 14 days every 4 weeks for six courses. " 04/01/1983 - "The patient was treated with cyclophosphamide and prednisone with a good clinical response, but within two years, histiocytic lymphoma developed. " 09/01/1983 - "Subacute polyneuropathy that responded to prednisone was the initial symptom in two patients, one of whom was later found to have histiocytic lymphoma and the other, chronic lymphocytic leukemia. " 11/08/2012 - "TP53 mutation is an independent marker of poor prognosis in patients with diffuse large B-cell lymphoma (DLBCL) treated with cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone (CHOP) therapy. " 12/01/2007 - "The CHOP (cyclophosphamide/doxorucibin/vincristine/prednisone) regimen has been established as the standard treatment for diffuse large B-cell lymphoma (DLBCL). "
4.	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/01/1959 - "[A case of reticulosarcoma treated with large doses of prednisone]." 10/02/1957 - "[Massive dosage of prednisone in lymphogranuloma, lymphosarcoma and reticulum cell sarcoma]." 02/01/1957 - "[Reticulosarcoma of the scapula; treatment with delta cortisone]." 09/01/2013 - "Treatments for high-, intermediate-, and low-grade lymphomas were divided into 4 groups: absence of treatment, chemotherapy with or without hydroxydaunorubicin, and only prednisone. " 09/01/2005 - "This therapy was modified from CHOP in the treatment of patients with non-Hodgkin's lymphoma: CTX 600 mg/m(2), VCR 1.1 mg/m(2) were administrated by intravenous infusion every 2-4 weeks, prednisone was given orally at 1 mg.kg(-1).d(-1) for seven days after each infusion. "
5.	Multiple Myeloma 01/01/1994 - "The purposes of this study were (1) to estimate the response rate of alternate-day high dose prednisone in patients with relapsing and refractory multiple myeloma; (2) to measure the rate of GR levels; and (3) to correlate the response of prednisone with GR status. " 01/01/1975 - "A study was designed to evaluate the effectiveness of prednisone therapy in poor-risk patients with multiple myeloma. " 05/01/2002 - "Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients." 01/01/1994 - "Alternate-day high-dose prednisone was well tolerated and may provide palliative benefit for a subset of patients with relapsing and refractory multiple myeloma. " 01/01/1994 - "Prednisone is an active drug in the treatment of multiple myeloma. "

Related Drugs and Biologics

1.	Cyclophosphamide (Cytoxan)
2.	Vincristine (Oncovin)
3.	Doxorubicin (Adriamycin)
4.	rituximab (Mabthera)
5.	Azathioprine (Imuran)
6.	Melphalan (Alkeran)
7.	Procarbazine (Matulane)
8.	Methotrexate (Mexate)
9.	docetaxel (Taxotere)
10.	Mitoxantrone (Novantrone)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Castration
3.	Combination Drug Therapy (Combination Chemotherapy)
4.	Aftercare (After-Treatment)
5.	Radiotherapy